A preliminary pharmacokinetic study of liposomal leuprolide dry powder inhaler: A technical note

被引：0
|
作者：
Shahiwala, A [1 ]
Misra, A [1 ]
机构：
[1] Maharaja Sayajirao Univ Baroda, Fac Engn & Technol, Dept Pharm, Vadodara 390001, Gujarat, India
来源：
AAPS PHARMSCITECH | 2005年 / 6卷 / 03期
关键词：
leuprolide acetate; pulmonary; dry powder inhaler; liposome; pharmacokinetics;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] A Comparative Bioavailability Study between a Marketed Capsule-based Levodopa Dry Powder Inhaler and a New Pre-filled Levodopa Dry Powder Inhaler
    van Laar, T.
    Grasmeijer, F.
    Hoppentocht, M.
    MOVEMENT DISORDERS, 2024, 39 : S324 - S325
  • [32] Use of a cognitive ergonomics approach to compare usability of a multidose dry powder inhaler and a capsule dry powder inhaler: An open-label, randomized, controlled study
    Franks, M
    Briggs, P
    CLINICAL THERAPEUTICS, 2004, 26 (11) : 1791 - 1799
  • [33] Dry powder inhaler deposition in the larynx and the risk of steroid inhaler laryngitis: A computational fluid dynamics study
    Dey, Shamudra
    Bock, Jonathan M.
    Garcia, Guilherme J. M.
    JOURNAL OF AEROSOL SCIENCE, 2025, 183
  • [34] Site-specific delivery of inhalable antiangiogenic liposomal dry powder inhaler technology ameliorates experimental pulmonary hypertension
    Dhoble, Sagar
    Ghodake, Vinod
    Peshattiwar, Vaibhavi
    Patravale, Vandana
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 62
  • [35] Investigation of sorafenib tosylate loaded liposomal dry powder inhaler for the treatment of non-small cell lung cancer
    Patel, Khushboo
    Bothiraja, Chellampillai
    Mali, Ashwin
    Kamble, Ravindra
    PARTICULATE SCIENCE AND TECHNOLOGY, 2021, 39 (08) : 990 - 999
  • [36] In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters
    Sahakijpijarn, Sawittree
    Moon, Chaeho
    Warnken, Zachary N.
    Maier, Esther Y.
    DeVore, Jennie E.
    Christensen, Dale J.
    Koleng, John J.
    Williams, Robert O.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS-X, 2021, 3
  • [37] Kinetics of emitted mass-A study with three dry powder inhaler devices
    Behara, Srinivas Ravindra Babu
    Kippax, Paul
    Larson, Ian
    Morton, David A. V.
    Stewart, Peter
    CHEMICAL ENGINEERING SCIENCE, 2011, 66 (21) : 5284 - 5292
  • [38] A pharmacokinetic/pharmacodynamic study comparing arformoterol tartrate inhalation solution and racemic formoterol dry powder inhaler in subjects with chronic obstructive pulmonary disease
    Kharidia, J.
    Fogarty, C. M.
    LaForce, C. F.
    Maier, G.
    Hsu, R.
    Dunnington, K. M.
    Curry, L.
    Baumgartner, R. A.
    Hanrahan, J. P.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (04) : 657 - 662
  • [39] Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler
    Kemp, JP
    Hill, MR
    Vaughan, LM
    Meltzer, EO
    Welch, MJ
    Ostrom, NK
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1997, 79 (04) : 322 - 326
  • [40] A Preference Study of Two Placebo Dry Powder Inhalers in Adults with COPD: ELLIPTA® Dry Powder Inhaler (DPI) versus DISKUS® DPI
    Kirby, Suyong Yun
    Zhu, Chang-Qing
    Kerwin, Edward M.
    Stanford, Richard H.
    Georges, George
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (02) : 167 - 175
12345